查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1715838

快速微生物檢測市場：2025-2030 年全球預測（按產品、檢測方法、樣品類型、應用和最終用戶）

Rapid Microbiology Testing Market by Product, Testing Method, Sample Type, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計快速微生物檢測市場在 2024 年的價值將達到 48.6 億美元，到 2025 年將以 7.59% 的複合年成長率成長至 52.2 億美元，到 2030 年將達到 75.4 億美元。

主要市場統計數據
基準年2024年 48.6億美元
預計2025年 52.2億美元
預測年份 2030 75.4億美元
複合年成長率（%） 7.59%

快速微生物檢測已成為臨床診斷、環境安全、工業品管和製藥領域的變革力量。在當今快節奏、精準驅動的環境中，及時且準確的微生物檢測從未如此重要。微生物學方法的演變不僅僅是一項科學追求，對於尋求降低風險、簡化決策和提高生產力的組織來說，它是一項策略必要事項。

本介紹描述了創新微生物技術的起源及其快速應用。加快檢測程序的需求既源自於醫療保健領域的新挑戰，也源自於環境和工業矩陣日益複雜的變化。技術的快速進步不僅大大縮短了測試時間，而且提高了檢測系統的可靠性和靈敏度。本報告深入探討了這些調查方法的細微差別，並強調了它們的應用和競爭優勢。

改進的技術與即時數據分析相結合正在徹底改變微生物學測試的方法。科學技術的融合正在推動向具有成本效益、擴充性的方法的轉變，從而使各行各業受益。本入門書將為理解為什麼快速微生物學檢測在當今充滿活力、相互連結的世界中至關重要奠定堅實的基礎。

改變快速微生物檢測市場

在不斷的技術創新和不斷變化的市場需求的推動下，快速微生物學檢測領域經歷了一系列的轉變。這項變化的核心是先進儀器和新分析技術的整合，重新定義了我們檢測和量化微生物存在的方式。

現代實驗室受益於利用自動化系統和人工智慧來簡化工作流程的最先進的設備。主動空氣採樣器和自動微生物鑑定系統對於減少體力勞動和提高產量至關重要。基於生物發光和螢光的檢測、細胞分析儀、質譜儀和 PCR 平台等系統在靈敏度和特異性方面設立了新的基準。透過實施這些先進的系統，即使是最小的微生物活動也可以可靠地識別，從而實現更準確的診斷和預防措施。

除了技術進步之外，更廣泛的市場正在發生重要的模式轉移。對更快、更有效率的測試的需求正在推動產業不斷突破極限。市場反應的特徵是對研發進行策略性投資，創造一個鼓勵和獎勵創新的環境。這一轉變階段標誌著向精準醫療和強力的環境、工業和品質保證通訊協定邁出的更大一步。

實驗室營運中數位轉型的整合，加上簡化的數據分析，使研究人員和從業人員能夠做出更明智的決策。這些變化凸顯了該行業的動態性質，該行業隨著技術進步和市場需求而不斷發展。

快速微生物學檢測市場的關鍵細分洞察

對於希望利用快速微生物學檢測不斷發展的趨勢的相關人員來說，全面了解市場區隔至關重要。市場按各個方面進行細分，每個維度都對產品創新、測試技術、特定樣品挑戰、特定應用和最終用戶偏好提供了獨特的見解。

依產品分析，市場全面調查耗材、儀器、試劑及試劑套件。具體來說，設備分為幾個專門的類別。主動空氣採樣器、自動微生物鑑定和抗菌敏感性測試系統在快速反應環境中提供關鍵支援。還有基於生物發光和螢光檢測的系統，以及推動微生物分析進步的細胞分析儀和質譜儀。此外，PCR 系統在基因識別和擴增方面發揮著至關重要的作用。

檢查方法為分割提供了另一個維度。市場顯示出層析法、質譜法和聚合酵素鏈鎖反應技術之間的明顯差異。在層析法中，氣相層析法和液相層析法分別滿足特定的分析需求，而質譜法又進一步細分為基質輔助雷射解吸電離法和飛行時間質譜法，以確保高靈敏度。聚合酵素鏈鎖反應進一步分為數位 PCR 和即時PCR，每種技術均旨在用於微生物檢測的不同目的。

基於樣本類型的分割突顯了背景在微生物分析中的重要性。測試通常在血液、組織和尿液樣本上進行，每種樣本都有其獨特的挑戰和要求。這種細分凸顯了需要針對每種樣本類型的獨特屬性制定客製化方法，從而最大限度地提高檢測準確性並確保結果的穩健性。

基於應用的細分進一步闡明了行業格局，將其分為臨床疾病診斷、環境測試、工業測試以及製藥和生物技術應用。工業測試專門從事化妝品和個人保健產品測試、食品和飲料測試、藥品和生物製藥測試。這種多方面的方法確保每個應用程式都按照其各自行業標準所需的精度進行處理。

根據最終用戶的最終細分考慮醫院、實驗室、製造業和公共部門。醫院又分為私立醫院和公立醫院，實驗室又包括臨床實驗室和研究機構。對製造業的分析重點是食品加工商和製藥商，反映了快速微生物檢測在不同業務模式下的多樣化應用。

這種市場區隔洞察提供了對市場的細緻觀察，並為市場參與企業提供了藍圖。了解各個細分市場的細微需求使相關人員能夠創新並策略性地定位他們的產品和服務。這種詳細的細分有助於確定成長領域、了解競爭動態並客製化解決方案以應對每個細分市場的獨特挑戰。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 快速微生物學檢測在感染疾病臨床診斷的應用日益增多
      • 在工業和環境測試應用中的快速應用
      • 政府對食品和水檢測的嚴格標準
    • 限制因素
      • 快速微生物檢測套組高成本
    • 機會
      • 用於遠端醫療和遠距離診斷的照護現場快速微生物檢測的開發
      • 快速微生物檢測整合人工智慧驅動的分析以提高準確性
    • 任務
      • 與快速微生物檢測解決方案相關的技術限制
  • 市場區隔分析
    • 測試方法：使用層析法分離化學混合物的現象正在迅速增加
    • 最終用戶：擴大醫院快速微生物檢測的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章快速微生物檢測市場（按產品）

  • 耗材
  • 裝置
    • 主動空氣採樣器
    • 自動化微生物鑑定及藥敏試驗系統
    • 生物發光和螢光檢測系統
    • 細胞分析儀
    • 質譜儀
    • PCR體系
  • 試劑和套件

7. 快速微生物檢測市場（依檢測方法）

  • 層析法
    • 氣相層析法
    • 液相層析法
  • 質譜法
    • 基質輔助雷射解吸/電離
    • 飛行時間質譜儀
  • 聚合酵素鏈鎖反應
    • 數位PCR
    • 即時PCR

8. 快速微生物學檢測市場（依樣本類型）

  • 血
  • 組織
  • 尿

第9章快速微生物檢測市場（依應用）

  • 臨床疾病診斷
  • 環境測試
  • 工業測試
    • 化妝品和個人保健產品測試
    • 食品和飲料測試
    • 藥物和生物測試
  • 製藥和生物技術

第 10 章快速微生物學檢測市場（按最終用戶）

  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究所
    • 臨床實驗室
    • 研究機構
  • 製造業
    • 食品加工機
    • 製藥商
  • 公共部門

第 11 章：美洲快速微生物學檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12. 亞太地區快速微生物檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲快速微生物檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析

第 14 章 3.5.透過快速微生物檢測加強深度處理：

  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • BTNX Inc.
  • Charles River Laboratories International, Inc.
  • Colifast AS
  • CorDx Inc
  • Danaher Corporation
  • Don Whitley Scientific Limited
  • Gradientech AB
  • Merck KGaA
  • NEOGEN Corporation
  • Paragon Genomics, Inc.
  • PerkinElmer, Inc.
  • Quidel Corporation
  • R-Biopharm AG
  • Rapid Micro Biosystems, Inc.
  • rqmicro AG
  • Sartorius AG
  • Serosep Ltd.
  • Thermo Fisher Scientific, Inc.
  • Vivione Biosciences Inc.
Product Code: MRR-5012464363FE

The Rapid Microbiology Testing Market was valued at USD 4.86 billion in 2024 and is projected to grow to USD 5.22 billion in 2025, with a CAGR of 7.59%, reaching USD 7.54 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.86 billion
Estimated Year [2025] USD 5.22 billion
Forecast Year [2030] USD 7.54 billion
CAGR (%) 7.59%

Rapid microbiology testing has emerged as a transformative force in the realms of clinical diagnostics, environmental safety, industrial quality control, and pharmaceutical excellence. In today's fast-paced and precision-driven landscape, the emphasis on timely, accurate microbial detection has never been more pronounced. The evolution of microbiological techniques is not just a scientific pursuit-it is a strategic imperative for organizations striving to mitigate risks, streamline decision-making, and enhance productivity.

In this introduction, we set the stage by exploring the origins and rapid adoption of innovative microbiological methods. The need for accelerated testing procedures is driven by both emerging challenges in healthcare and the growing complexity of environmental and industrial matrices. The rapid technological advancements have not only shortened the turnaround times significantly but have also improved the reliability and sensitivity of detection systems. As we navigate this report, we delve into the nuances of these methodologies, shedding light on their applications and the competitive advantage they offer.

Technological improvements combined with real-time data analytics are revolutionizing how microbial testing is approached. The convergence of science and technology is fueling a shift towards methodologies that are both cost-effective and scalable, thereby benefiting a diverse spectrum of industries. This introductory section lays a solid foundation for understanding why rapid microbiology testing is indispensable in today's dynamic and interconnected world.

Transformative Shifts in the Rapid Microbiology Testing Landscape

The landscape of rapid microbiology testing has experienced a series of transformative shifts, driven by relentless innovation and evolving market demands. At the heart of these changes is the integration of advanced instrumentation and novel analytical techniques which have redefined the way microbial presence is detected and quantified.

Modern laboratories now benefit from state-of-the-art equipment that leverages automated systems and artificial intelligence to streamline workflows. Active air samplers and automated microbial identification systems have been pivotal in reducing manual intervention and increasing throughput. Systems such as bioluminescence and fluorescence-based detection, cytometers, mass spectrometers, and PCR platforms have set new benchmarks in sensitivity and specificity. The implementation of these advanced systems ensures that even minute microbial activities are identified, thereby enabling more precise diagnostic and preventative measures.

Beyond technological advancements, the broader market has also witnessed important paradigm shifts. The demand for faster, more efficient testing is propelling the industry to continually push boundaries. The market response has been characterized by strategic investments in research and development, fostering an environment where innovation is both encouraged and rewarded. This transformative phase is indicative of a larger move towards precision medicine and robust environmental, industrial, and quality assurance protocols.

The integration of digital transforms in lab operations, coupled with streamlined data analytics, has made it possible for researchers and practitioners to make more informed decisions. Collectively, these shifts underscore the dynamic nature of the industry as it continues to evolve in response to both technological advancements and market imperatives.

Key Segmentation Insights in the Rapid Microbiology Testing Market

A comprehensive understanding of market segmentation is critical for stakeholders aiming to capitalize on the evolving trends in rapid microbiology testing. The market is segmented along various dimensions, each offering unique insights into product innovations, testing methodologies, sample-specific challenges, particular applications, and the preferences of end users.

When analyzing based on product, the market is comprehensively studied across consumables, instruments, and reagents and kits. Instruments in particular are dissected further into several specialized categories. Active air samplers, automated microbial identification, and antimicrobial susceptibility testing systems provide crucial support in settings that require quick turnaround. There are also systems based on bioluminescence and fluorescence detection, along with cytometers and mass spectrometers that have driven advancements in microbial analysis. Moreover, PCR systems play an indispensable role by offering precision in genetic identification and amplification.

Testing methods provide another dimension of segmentation. The market exhibits significant differentiation among chromatography, mass spectrometry, and polymerase chain reaction techniques. Within chromatography, gas chromatography and liquid chromatography each cater to specific analytical needs, while mass spectrometry has further branches characterized by matrix-assisted laser desorption ionization and time-of-flight mass spectrometry, ensuring high sensitivity. The polymerase chain reaction is segmented further into digital PCR and real-time PCR, each designed to meet distinct objectives in microbial detection.

Segmentation based on sample type highlights the importance of context in microbial analysis. Commonly, testing is performed on blood, tissue, and urine samples, each presenting unique challenges and requirements. This segmentation underlines the need for tailored methodologies that address the intrinsic qualities of each sample type, thereby maximizing the accuracy of detection and ensuring robustness in results.

Application-based segmentation further demystifies the landscape by categorizing testing into clinical disease diagnostics, environmental testing, industrial testing, and pharmaceutical and biotechnology applications. Industrial testing itself is nuanced, with specific practices for cosmetics and personal care product testing, food and beverage testing, as well as pharmaceutical and biological drug testing. This multifaceted approach ensures that each application is addressed with the precision required by the respective industry standards.

The final segmentation based on the end user considers hospitals, laboratories, the manufacturing industry, and the public sector. Hospitals are further divided into private and public sectors, while laboratories include both clinical laboratories and research institutes. The manufacturing industry is analyzed with attention to food processors and pharmaceutical manufacturers, reflecting the diverse application of rapid microbiology testing across different operational paradigms.

These segmentation insights provide a granular view of the market and offer a roadmap for industry participants. By understanding the nuanced requirements across various segments, stakeholders are better positioned to innovate and strategically position their products and services. This detailed segmentation is instrumental in identifying areas of growth, understanding competitive dynamics, and tailoring solutions to meet the unique challenges of each segment.

Based on Product, market is studied across Consumables, Instruments, and Reagents & Kits. The Instruments is further studied across Active Air Samplers, Automated Microbial Identification & Antimicrobial Susceptibility Testing System, Bioluminescence & Fluorescence-Based Detection System, Cytometers, Mass Spectrometers, and PCR Systems.

Based on Testing Method, market is studied across Chromatography, Mass Spectrometry, and Polymerase Chain Reaction. The Chromatography is further studied across Gas Chromatography and Liquid Chromatography. The Mass Spectrometry is further studied across Matrix-Assisted Laser Desorption Ionization and Time-Of-Flight MS. The Polymerase Chain Reaction is further studied across Digital PCR and Real-Time PCR.

Based on Sample Type, market is studied across Blood, Tissue, and Urine.

Based on Application, market is studied across Clinical Disease Diagnostics, Environmental Testing, Industrial Testing, and Pharmaceutical & Biotechnology. The Industrial Testing is further studied across Cosmetics & Personal Care Products Testing, Food & Beverage testing, and Pharmaceutical & Biological Drug Testing.

Based on End User, market is studied across Hospitals, Laboratories, Manufacturing Industry, and Public Sector. The Hospitals is further studied across Private Hospitals and Public Hospitals. The Laboratories is further studied across Clinical Laboratories and Research Institutes. The Manufacturing Industry is further studied across Food Processors and Pharmaceutical Manufacturers.

Key Regional Insights in the Global Market

The rapid microbiology testing market exhibits distinctive regional dynamics, with varying trends and growth catalysts apparent across different geographies. In the Americas, robust investment in healthcare infrastructure and stringent regulatory frameworks are driving a surge in demand for rapid diagnostic tools. The region's focus on integration of advanced technological systems for timely and efficient testing underscores a broader commitment to enhancing public and private healthcare standards.

Across the Europe, Middle East & Africa regions, dynamic socio-economic conditions and evolving policy directives are shaping the market. Collaborative efforts in research and innovation, coupled with a keen focus on quality assurance in clinical settings, are propelling the adoption of rapid microbiology testing. The challenging regulatory environment in these regions has fostered a need for solutions that are both compliant and adaptable, further stimulating industry innovation.

Asia-Pacific is witnessing significant growth due to rapid urbanization, increasing healthcare budgets, and a surging demand for cost-effective diagnostic tools. This region's market is marked by expansive growth opportunities as investments in infrastructure and technology continue to rise. The local emphasis on integrating automation with traditional testing methodologies has accelerated the market's adoption across various sectors. As these regions continue to evolve, their distinct market drivers offer a complex but rich landscape for rapid microbiology testing technologies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Shaping the Rapid Microbiology Testing Landscape

The industry is bolstered by the presence of several major companies that continue to shape the rapid microbiology testing landscape with cutting-edge technology and innovative solutions. Notable industry leaders include Abbott Laboratories, Becton, Dickinson and Company, and bioMerieux SA, all of which have a long-standing reputation for excellence in diagnostic solutions. Bruker Corporation, BTNX Inc., and Charles River Laboratories International, Inc. are also prominent, pushing forward with research and development initiatives that enhance testing efficiencies.

Companies such as Colifast AS and CorDx Inc, alongside industry giants like Danaher Corporation and Don Whitley Scientific Limited, are recognized for their contributions in refining microbial detection methodologies. Other key players, including Gradientech AB and Merck KGaA, consistently invest in advanced research to meet the evolving demands of the market. NEOGEN Corporation and Paragon Genomics, Inc. have also carved out significant niches, offering highly specialized solutions that cater to specific testing needs.

Further, PerkinElmer, Inc., Quidel Corporation, and R-Biopharm AG have garnered attention through their comprehensive portfolio of testing instruments and analytical techniques. The rapid evolution of this market is also reflected in the initiatives of companies like Rapid Micro Biosystems, Inc., rqmicro AG, and Sartorius AG, all of which are instrumental in setting new benchmarks for rapid and reliable testing. Additionally, Serosep Ltd., Thermo Fisher Scientific, Inc., and Vivione Biosciences Inc. are continuously innovating to deliver actionable insights and technologies that further the capabilities available in rapid microbiology testing. These companies not only drive technological advancements but also serve as benchmarks for quality, innovation, and customer trust in the industry.

The report delves into recent significant developments in the Rapid Microbiology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bruker Corporation, BTNX Inc., Charles River Laboratories International, Inc., Colifast AS, CorDx Inc, Danaher Corporation, Don Whitley Scientific Limited, Gradientech AB, Merck KGaA, NEOGEN Corporation, Paragon Genomics, Inc., PerkinElmer, Inc., Quidel Corporation, R-Biopharm AG, Rapid Micro Biosystems, Inc., rqmicro AG, Sartorius AG, Serosep Ltd., Thermo Fisher Scientific, Inc., and Vivione Biosciences Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to strategically position themselves by focusing on continuous innovation and robust market engagement. First, it is crucial for organizations to invest in research and development that targets the integration of automation, digital analytics, and high-throughput systems. By deploying next-generation sequencing technologies and enhanced mass spectrometric methodologies, companies can fine-tune their instruments for improved sensitivity and faster turnaround times.

Furthermore, staying current with regulatory compliance across different regional markets is paramount. Leaders should establish dedicated compliance teams that work in tandem with R&D departments to ensure that new technologies and testing approaches meet stringent regulatory standards. Leveraging partnerships with regional experts and regulatory consultants can support this initiative by providing nuanced insights into local compliance requirements.

Another key recommendation is to build a diversified portfolio that addresses a wide range of testing methods, sample types, and applications. By offering solutions that cater to clinical diagnostics, environmental testing, industrial quality assurance, and pharmaceutical processes, organizations can tap into multiple revenue streams. This diversified approach not only mitigates risk but also broadens market reach.

Further, direct engagement with end users through customized service packages and dedicated support channels can help in building long-term relationships and brand loyalty. Tailoring solutions to meet the specific needs of hospitals, laboratories, manufacturing industries, and public sector organizations is essential. Proactive client engagement initiatives, such as hands-on workshops, user training sessions, and roundtable discussions, are valuable in gathering user feedback and driving subsequent innovation.

Leveraging strategic geographic expansion is another actionable recommendation. Companies should analyze regional trends carefully and consider establishing localized centers of excellence. Such centers can serve as hubs for research, development, and customer support, thereby facilitating a deeper understanding of regional market dynamics and faster deployment of solutions.

Finally, fostering a culture of collaboration both internally and externally can yield significant benefits. Partnership with academic institutions, collaborative research consortia, and cross-industry innovation hubs can spur breakthroughs that translate into more efficient and cost-effective rapid microbiology testing solutions. This multi-faceted approach will enable industry leaders to not only adapt to current market trends but also set the pace for future developments.

Conclusion: Embracing a New Era in Microbiology Testing

In conclusion, the future of rapid microbiology testing is characterized by innovation, precision, and a commitment to quality. The integration of advanced technologies, coupled with comprehensive market segmentation, has redefined how microbial detection is approached across various industries. By analyzing the market from multiple perspectives-be it product lines, testing methodologies, sample types, application areas, or end user demands-the industry is poised to offer solutions that are both groundbreaking and deeply practical.

The regional dynamics further underscore the varied yet interconnected growth opportunities around the globe. With robust markets in the Americas, Europe, Middle East & Africa, and Asia-Pacific, there is a clear mandate for localized strategies that address unique regional demands. Companies that can navigate these nuanced landscapes while adhering to global standards are well-positioned to lead in this transformative era.

Moreover, the industry is supported by a suite of dynamic companies that continue to drive innovation and set new standards for rapid, reliable testing. The collective efforts of these organizations have paved the way for a future where diagnostic testing is not just fast but exceedingly precise. As we reflect on the current state and future prospects of rapid microbiology testing, it becomes evident that the journey ahead is filled with promising opportunities for growth and advancement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of rapid microbiology testing for clinical diagnosis of infectious diseases
      • 5.1.1.2. Rapid adoption in industrial and environmental testing applications
      • 5.1.1.3. Strict government standards for food and water testing
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with rapid microbiology testing kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing point-of-care rapid microbiological tests for telehealth and remote diagnostics
      • 5.1.3.2. Integration of AI-driven analytics in rapid microbiological testing for enhanced accuracy
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations associated with rapid microbial testing solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Testing Method: Proliferating use of chromatography testing method for separating chemical mixtures
    • 5.2.2. End User: Expanding utilization of rapid microbiology testing in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Rapid Microbiology Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
    • 6.3.1. Active Air Samplers
    • 6.3.2. Automated Microbial Identification & Antimicrobial Susceptibility Testing System
    • 6.3.3. Bioluminescence & Fluorescence-Based Detection System
    • 6.3.4. Cytometers
    • 6.3.5. Mass Spectrometers
    • 6.3.6. PCR Systems
  • 6.4. Reagents & Kits

7. Rapid Microbiology Testing Market, by Testing Method

  • 7.1. Introduction
  • 7.2. Chromatography
    • 7.2.1. Gas Chromatography
    • 7.2.2. Liquid Chromatography
  • 7.3. Mass Spectrometry
    • 7.3.1. Matrix-Assisted Laser Desorption Ionization
    • 7.3.2. Time-Of-Flight MS
  • 7.4. Polymerase Chain Reaction
    • 7.4.1. Digital PCR
    • 7.4.2. Real-Time PCR

8. Rapid Microbiology Testing Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Tissue
  • 8.4. Urine

9. Rapid Microbiology Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinical Disease Diagnostics
  • 9.3. Environmental Testing
  • 9.4. Industrial Testing
    • 9.4.1. Cosmetics & Personal Care Products Testing
    • 9.4.2. Food & Beverage testing
    • 9.4.3. Pharmaceutical & Biological Drug Testing
  • 9.5. Pharmaceutical & Biotechnology

10. Rapid Microbiology Testing Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Laboratories
    • 10.3.1. Clinical Laboratories
    • 10.3.2. Research Institutes
  • 10.4. Manufacturing Industry
    • 10.4.1. Food Processors
    • 10.4.2. Pharmaceutical Manufacturers
  • 10.5. Public Sector

11. Americas Rapid Microbiology Testing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Rapid Microbiology Testing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Rapid Microbiology Testing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Oculer gains AOAC approval, boosting rapid microbiology testing for UHT milk
    • 14.3.2. bioMerieux and AnaBioTec partner to accelerate rapid mycoplasma testing for enhanced biopharma and CGT efficiency
    • 14.3.3. Samsung and Rapid Micro Biosystems partner to deploy Growth Direct platform
    • 14.3.4. The Forge of Collaborative Innovation in Microbial Testing Elevating Pharmaceutical Standards

14.3.5. Enhancing Advanced Therapies through Swift Microbial Testing:

  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. bioMerieux SA
  • 4. Bruker Corporation
  • 5. BTNX Inc.
  • 6. Charles River Laboratories International, Inc.
  • 7. Colifast AS
  • 8. CorDx Inc
  • 9. Danaher Corporation
  • 10. Don Whitley Scientific Limited
  • 11. Gradientech AB
  • 12. Merck KGaA
  • 13. NEOGEN Corporation
  • 14. Paragon Genomics, Inc.
  • 15. PerkinElmer, Inc.
  • 16. Quidel Corporation
  • 17. R-Biopharm AG
  • 18. Rapid Micro Biosystems, Inc.
  • 19. rqmicro AG
  • 20. Sartorius AG
  • 21. Serosep Ltd.
  • 22. Thermo Fisher Scientific, Inc.
  • 23. Vivione Biosciences Inc.

LIST OF FIGURES

  • FIGURE 1. RAPID MICROBIOLOGY TESTING MARKET MULTI-CURRENCY
  • FIGURE 2. RAPID MICROBIOLOGY TESTING MARKET MULTI-LANGUAGE
  • FIGURE 3. RAPID MICROBIOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 4. RAPID MICROBIOLOGY TESTING MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. RAPID MICROBIOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. RAPID MICROBIOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. RAPID MICROBIOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RAPID MICROBIOLOGY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ACTIVE AIR SAMPLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY AUTOMATED MICROBIAL IDENTIFICATION & ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BIOLUMINESCENCE & FLUORESCENCE-BASED DETECTION SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MATRIX-ASSISTED LASER DESORPTION IONIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TIME-OF-FLIGHT MS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOLOGICAL DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD PROCESSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PUBLIC SECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 83. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 84. ARGENTINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 97. BRAZIL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 252. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 265. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 278. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 280. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 291. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 292. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 293. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 294. THAILAND RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2030 (USD MILLION)
  • TABLE 304. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 305. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 306. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES, 2018-2030 (USD MILLION)
  • TABLE 307. VIETNAM RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MANUFACTURING INDUSTRY, 2018-2030 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TESTING METHOD, 2018-2030 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA